Lennon et al. investigated the role of MOR overexpression in NSCLC [31], and their results indicate that MOR stimulates cell progression via EGFR-dependent PI3K/AKT/mTOR signaling pathway activation [7,31]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.